Health Imaging

JULY 29, 2024

According to the DOJ, the pharmacist and those working under him “would ‘fractionate’ or ‘split’ the active ingredient of Technescan MAG3, without ensuring the pieces were equal in size, purity or strength.”

Radiopharmaceuticals 279

Radiopharmaceuticals 279

AuntMinnie

MARCH 26, 2025

Ultimately, most hospitals conducting trials receive doses of these eight radionuclides from upstream radiopharmaceutical production facilities, with U.S. Moreover, several of these eight are being used to co-develop SPECT and PET imaging agents in the field of theranostics.

Nuclear Medicine 207

Nuclear Medicine Radiopharmaceuticals Patient Care Hospital 207

Radiology Business

NOVEMBER 20, 2024

The Australian company will secure exclusive worldwide rights to a suite of diagnostic and therapeutic candidates geared toward urological cancers.

Radiopharmaceuticals 264

Radiopharmaceuticals Diagnostic Imaging 264

Radiology Business

JULY 23, 2024

The Melbourne, Australia-based radiopharmaceutical firm plans to use the proceeds to accelerate development of products in its theranostics portfolio

Pharmaceutical 298

Pharmaceutical Radiopharmaceuticals Imaging IT 298

Radiology Business

SEPTEMBER 23, 2024

RLS operates America’s only Joint Commission-accredited radiopharmacy network, with 31 locations covering over 85% of the U.S. population.

Radiopharmaceuticals 262

Radiopharmaceuticals Imaging 262

AuntMinnie

MARCH 5, 2025

TerraPower recently shipped its first batch ofAc-225 through the project, and boasts more than 10 supply agreements with radiopharmaceutical developers in the U.S., So, if you do that math, it's about 90,000 millicuries per year that we would expect to be harvesting once our supply chain is at scale, he said. Canada, Australia, and in Europe.

Nuclear Medicine 200

Nuclear Medicine Radiopharmaceuticals IT Clinic 200

Radiology Business

JULY 12, 2024

For years, the agency has packaged payment for nuclear imaging agents with the procedure, but this has created a barrier for those who require pricier new drugs.

Radiopharmaceuticals 260

Radiopharmaceuticals Diagnostic Imaging 260

AuntMinnie

MAY 8, 2024

Three clinical issues that may arise with theranostics treatments will require special provisions, including spot imaging, according to insights shared during the 124th annual meeting of the American Roentgen Ray Society (ARRS) in Boston. Spot imaging revealed that more than half of the administered activity was in the patient's arm.

Radiopharmaceuticals 189

Radiopharmaceuticals Nuclear Medicine Radiation Hospital 189

Health Imaging

JANUARY 8, 2024

The new facility is run by Novartis and is being called the “most advanced of its kind."

Radiopharmaceuticals 274

Radiopharmaceuticals IT 274

AuntMinnie

APRIL 4, 2024

Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.

Radiopharmaceuticals 238

Radiopharmaceuticals Imaging Disease Diagnostic 238

Health Imaging

APRIL 5, 2024

The supply agreement with Eckert & Ziegler will ensure radiopharmaceuticals are available for PET imaging and cancer treatment plans.

Radiopharmaceuticals 276

Radiopharmaceuticals IT Imaging 276

AuntMinnie

JUNE 22, 2023

Read more on AuntMinnie.com Related Reading: RLS appoints new director of regulatory affairs SpectronRx, RLS ink radiopharmaceutical supply deal RLS lands radiopharmaceutical supplier deal from Premier Sofie to launch FAPI-PET phase II trial First patient imaged in Sofie's FAPI-PET trial

Radiopharmaceuticals 130

Radiopharmaceuticals Imaging 130

AuntMinnie

MARCH 25, 2025

Actinium will continue developing its lead radiopharmaceutical product Actimab-A, as well as additional early and late-stage development candidates for both U.S. Demand for Ac-225 is driven in part by the rapid development of theranostic "pairs" used in imaging and therapy. and international clinical trials.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Clinic IT 130

AuntMinnie

OCTOBER 14, 2024

The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise, and new guidelines on their use can help pave the way to improved outcomes for patients, experts noted in a recent article. In the U.S., The full article is available here.

Nuclear Medicine 276

Nuclear Medicine Radiopharmaceuticals Insurance Clinic 276

AuntMinnie

FEBRUARY 26, 2025

The new horizons of advanced imaging, especially in oncology, must increasingly consider not only diagnostic efficacy but also sustainability for patients, prize-winning researchers told ECR 2025 delegates. To mitigate these effects, low-energy imaging techniques should be prioritized without compromising diagnostic accuracy.

Bone Scan 130

Bone Scan Radiopharmaceuticals Imaging Modalities Bone Scintigraphy 130

AuntMinnie

SEPTEMBER 13, 2023

The Medical Imaging and Technology Alliance (MITA) has raised concerns ove. Senate MITA hails radiopharmaceutical legislation

Radiopharmaceuticals 130

Radiopharmaceuticals PET Scan Medical Imaging Disease 130

AuntMinnie

DECEMBER 8, 2023

Organizing pneumonia can hide underlying lung cancers in up to 10% of cases, and repeat imaging in the form of PET/CT -- and additional biopsy -- should be considered in patients with high clinical suspicion of malignancy, researchers have reported.

Imaging 309

Imaging Radiopharmaceuticals Disease Diagnose 309

Imaging Technology

NOVEMBER 7, 2024

Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures. tim.hodson Thu, 11/07/2024 - 11:25 Nov.

Nuclear Medicine 97

Nuclear Medicine Radiopharmaceuticals Medicare Diagnostic 97

Health Imaging

MARCH 7, 2025

Trial results thus far indicate the drug can significantly extend progression-free survival compared to current standard of care treatments.

Radiopharmaceuticals 174

Radiopharmaceuticals 174

AuntMinnie

DECEMBER 11, 2023

Key corporate members and staff from the Medical Imaging Technology Alliance (MITA) are launching a new medical imaging technology division at medical technology trade association Advanced Medical Technology Association (AdvaMed).

Imaging 278

Imaging Medical Imaging Radiopharmaceuticals Medical 278

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Beyder led a theranostics practice management and logistics track at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Toronto.

Nuclear Medicine 264

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 264

AuntMinnie

MARCH 7, 2024

In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging. 1033 to speak with a representative.

PET Scan 290

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 290

AuntMinnie

MARCH 27, 2025

Flyrcadois a unit-dose PET myocardial perfusion imaging (MPI) agent intended for patients with known or suspected coronary artery disease. Pass-through payment status will allow the CMS to provide separate payments for the radiopharmaceutical and the PET-CT scan when performed with Flyrcado in the hospital outpatient setting.

Healthcare 130

Healthcare Healthcare Medicare Radiopharmaceuticals 130

AuntMinnie

NOVEMBER 12, 2024

His lab team is currently focused on "implementing advanced techniques, such as parallel transmit, to achieve more consistent image quality and fully harness the power of 7T for every patient," Middlebrooks said. Avoiding certain sequences due to difficulties at 7T is not always practical.

Radiologist 360

Radiologist Education Clinic Radiology 360

AuntMinnie

SEPTEMBER 30, 2024

A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. Nearly 80% of patients in our study were progression-free after six months," he said.

Radiation Oncology 299

Radiation Oncology Radiopharmaceuticals Radiation Clinic 299

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., Siegel told AuntMinnie.com. "My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 264

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiographer Radiographer 306

Imaging Technology

OCTOBER 17, 2023

a clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, is pleased to announce that the first subject has been dosed in its Phase 1 study of 68Ga-R8760. milla1cf Tue, 10/17/2023 - 13:07 October 17, 2023 — Radionetics Oncology, Inc.,

Radiopharmaceuticals 116

Radiopharmaceuticals Disease Clinic Diagnose 116

Imaging Technology

JULY 25, 2023

The ubiquitous expression of FAP in cancer-associated fibroblasts across nearly all epithelial-derived cancers paired with the low abundance in normal tissues, makes it a unique target to exploit for tumor imaging for a wide variety of cancers such as breast, pancreatic, lung and stomach cancer.

Radiopharmaceuticals 98

Radiopharmaceuticals Imaging Pharmaceutical Disease 98

Imaging Technology

MAY 10, 2024

milla1cf Fri, 05/10/2024 - 08:08 May 10, 2024 — Mariana Oncology , a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer , today announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments.

Radiopharmaceuticals 95

Radiopharmaceuticals Clinic IT 95

AuntMinnie

JUNE 9, 2024

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer award on Carolyn Anderson, PhD, of the University of Missouri-Columbia (MU). Image courtesy of SNMMI. Carolyn Anderson, PhD, of the University of Missouri-Columbia.

Nuclear Medicine 246

Nuclear Medicine Radiopharmaceuticals Disease Imaging 246

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Medicare 130

Medicare Nuclear Medicine Radiopharmaceuticals Imaging 130

Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). It can also be used for beta-particle targeted RPT using copper isotopes.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

Diagnostic Imaging

NOVEMBER 15, 2024

In an interview, SNMMI president Cathy Cutler, PhD, discussed the impact of the recent CMS decision to unbundle reimbursement for diagnostic radiopharmaceuticals costing above $630 a day, calling it a “game changer” decision that will benefit patients, physicians, and the development of new radiopharmaceutical agents.

Radiopharmaceuticals 81

Radiopharmaceuticals Diagnostic IT 81

AuntMinnie

JUNE 6, 2023

Read more on AuntMinnie.com Related Reading: KA Imaging lands radiography supply contract from Premier Premier gives Canon Supplier Legacy Award GE sells radiopharmacy network to RLS Elekta secures 5-year Premier contract Guerbet wins group purchasing agreement from Premier

Radiopharmaceuticals 130

Radiopharmaceuticals Nuclear Medicine Radiography Imaging 130

Open Medscience

NOVEMBER 17, 2023

Gallium, predicted by Mendeleev, now revolutionises medical diagnostics with its unique radiopharmaceutical applications in oncology. The post Gallium Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.

Radiopharmaceuticals 59

Radiopharmaceuticals Medical Imaging Medical Imaging 59

Imaging Technology

APRIL 10, 2024

an investigational radiohybrid (rh) Prostate-Specific Membrane Antigen-targeted therapeutic radiopharmaceutical, is the lead candidate in Blue Earth Therapeutics’ oncology development program of next generation therapeutic radiopharmaceuticals. 177Lu-rhPSMA-10.1,

Radiopharmaceuticals 105

Radiopharmaceuticals Radiosensitivity Medical Diagnostic 105